Compare INDP & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDP | LDWY |
|---|---|---|
| Founded | 2000 | 1990 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 6.2M |
| IPO Year | N/A | 1991 |
| Metric | INDP | LDWY |
|---|---|---|
| Price | $3.01 | $4.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 14.1K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | ★ $69,769,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.07 |
| Revenue Growth | N/A | ★ 121.91 |
| 52 Week Low | $1.65 | $3.11 |
| 52 Week High | $47.60 | $6.19 |
| Indicator | INDP | LDWY |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 69.51 |
| Support Level | N/A | $3.45 |
| Resistance Level | N/A | $3.88 |
| Average True Range (ATR) | 0.00 | 0.16 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 0.00 | 84.70 |
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in industries: Specialty Ag, consisting of the Bloomia business.